Fortrea Holdings (FTRE) Non Operating Income (2023 - 2026)
Fortrea Holdings (FTRE) posted Non Operating Income of -$19.1 million for Q1 2026, up 17.67% on a QoQ basis from -$23.2 million in Q4 2025, and up 14.35% year-over-year from -$16.7 million in Q1 2025.
Fortrea Holdings (FTRE) Non Operating Income (2023 - 2026) Analysis & Trends
Fortrea Holdings' Non Operating Income history runs 4 years deep, the most recent figure standing at -$19.1 million for Q1 2026.
- Quarterly Non Operating Income rose 14.35% year-over-year to -$19.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$88.2 million (up 21.11% YoY) and the FY2025 annual result came in at -$91.4 million, up 26.17% from the prior year.
- Non Operating Income was -$19.1 million for Q1 2026 at Fortrea Holdings, up from -$23.2 million in the prior quarter.
- Across five years, Non Operating Income topped out at -$700000.0 in Q2 2023 and bottomed at -$45.2 million in Q2 2024.
- A 4-year average of -$25.3 million and a median of -$22.9 million in 2025 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2024 — Non Operating Income plunged 6357.14% — and 2025, when it soared 48.45%.
- Fortrea Holdings' Non Operating Income stood at -$34.5 million in 2023, then soared by 36.52% to -$21.9 million in 2024, then retreated by 5.94% to -$23.2 million in 2025, then gained by 17.67% to -$19.1 million in 2026.
- Business Quant data shows FTRE's Non Operating Income at -$19.1 million in Q1 2026, -$23.2 million in Q4 2025, and -$22.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | -19.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.10 Mn |
| Dec 31, 2025 | -23.20 Mn |
| Sep 30, 2025 | -22.60 Mn |
| Jun 30, 2025 | -23.30 Mn |
| Mar 31, 2025 | -22.30 Mn |
| Dec 31, 2024 | -21.90 Mn |
| Sep 30, 2024 | -22.40 Mn |
| Jun 30, 2024 | -45.20 Mn |
| Mar 31, 2024 | -34.30 Mn |
| Dec 31, 2023 | -34.50 Mn |
| Sep 30, 2023 | -34.60 Mn |
| Jun 30, 2023 | -700,000.00 |